We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $86.5M
This Fund
S&P 500
This Quarter Est. Return
-21.02%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.3M
AUM Growth
-$26.6M
Cap. Flow
-$16.7M
Cap. Flow %
-78.3%
Top 10 Hldgs %
66.69%
Holding
94
New
24
Increased
–
Reduced
32
Closed
17

Top Buys

Rank Stock Value
1
TCBPW
TC BioPharm (Holdings) plc Warrants
TCBPW
+$1.31M
2
SBFM
Sunshine Biopharma
SBFM
+$1.12M
3
BRCC.WS
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
+$855K
4
VLNS
The Valens Company, Inc. Common Shares
VLNS
+$854K
5
SLNO
Soleno Therapeutics
SLNO
+$484K

Top Sells

Rank Stock Value
1
ISPC icon
iSpecimen
ISPC
+$3.64M
2
OHAA
OPY Acquisition Corp. I Class A Common Stock
OHAA
+$2.96M
3
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.43M
4
RNERU
Mount Rainier Acquisition Corp. Unit
RNERU
+$2.03M
5
CCTSU
Cactus Acquisition Corp. 1 Limited Unit
CCTSU
+$2.02M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.67%
2 Healthcare 19.72%
3 Technology 3.09%
4 Consumer Staples 1.98%
5 Energy 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GFAIW icon
26
Guardforce AI Warrant
GFAIW
$6K
$115K 0.54%
301,563
-13,437
-4% -$3.68K
BFRIW icon
27
Biofrontera
BFRIW
$42.4K
$110K 0.52%
75,000
– –
GIWWW
28
DELISTED
GigInternational1, Inc. Warrant
GIWWW
$108K 0.51%
299,999
– –
AGTC
29
DELISTED
Applied Genetic Technologies Corporation
AGTC
$107K 0.5%
+100,000
New +$182K
STAB
30
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$105K 0.49%
+333,016
New +$356K
NRSNW icon
31
NeuroSense Therapeutics Warrant
NRSNW
$1.63M
$96K 0.45%
160,000
– –
AUUDW
32
DELISTED
Auddia Inc Warrants
AUUDW
$88K 0.41%
150,000
– –
MTEKW icon
33
Maris-Tech Ltd Warrants
MTEKW
$88K 0.41%
+297,600
New +$107K
GROY.WS
34
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$88K 0.41%
112,000
– –
CYTHW
35
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$87K 0.41%
63,036
-1,964
-3% -$3.51K
IMPP icon
36
Imperial Petroleum
IMPP
$229M
$83K 0.39%
+3,833
New +$108K
GRNAW
37
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$72K 0.34%
93,837
-6,163
-6% -$4.51K
AMPGW
38
DELISTED
Amplitech Group Warrants
AMPGW
$69K 0.32%
71,709
-3,291
-4% -$3.16K
FGIWW
39
FGI Industries Warrant
FGIWW
$100K
$68K 0.32%
+102,500
New +$69.8K
PRPC.WS
40
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$68K 0.32%
110,014
-6,762
-6% -$4.84K
AENTW icon
41
Alliance Entertainment Holding Corp Warrants
AENTW
$3.6M
$64K 0.3%
+199,999
New +$73K
PETVW
42
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$64K 0.3%
193,290
-6,710
-3% -$2.6K
OHAAW
43
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$60K 0.28%
148,800
-1,200
-0.8% -$540
INM icon
44
InMed Pharmaceuticals
INM
$7.69M
$58K 0.27%
+123
New +$64.5K
PCTTW
45
PureCycle Technologies Inc Warrant
PCTTW
$14.7M
$57K 0.27%
20,014
-2,359
-11% -$6.09K
TGVCW
46
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$49K 0.23%
238,428
-11,572
-5% -$3.25K
BBLGW
47
Bone Biologics Corp Warrants
BBLGW
$25M
$48K 0.23%
4,682
-80
-2% -$1.07K
RNERW
48
DELISTED
Mount Rainier Acquisition Corp. Warrant
RNERW
$48K 0.23%
+190,764
New +$41.5K
KWAC.WS
49
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$45K 0.21%
319,125
– –
NXGLW icon
50
NexGel Inc Warrant
NXGLW
$37.2K
$40K 0.19%
90,000
– –
1
2
3 4

Similar funds

BCM
Beaumont Capital Management Boston, Massachusetts $86.4M AUM 20.04% 1-Year Est. Return
TI
Truxt Investmentos Rio De Janeiro, Brazil $86.6M AUM
LCM
LDR Capital Management New York $86.7M AUM 16.32% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $86.7M AUM
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $86.1M AUM
TWM
Tripletail Wealth Management Orlando, Florida $86.9M AUM 39.01% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Empery Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Empery Asset Management held 94 positions worth $21.3M, down 56% from $47.9M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Empery Asset Management withdrew a net $16.7M in Q1 2022, closing 17 positions and reducing 32 holdings. Its most notable exit was iSpecimen, an estimated $3.64M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Empery Asset Management opened a new position in TC BioPharm (Holdings) plc Warrants worth $1.38M.

  • Empery Asset Management's largest Q1 2022 buy was TC BioPharm (Holdings) plc Warrants: 2,823,528 shares worth $1.38M.
  • Empery Asset Management's biggest Q1 2022 reduction was Starling Oncology, cutting an estimated $872K.
  • Empery Asset Management fully exited iSpecimen in Q1 2022, selling an estimated $3.64M.
  • Empery Asset Management's ten largest holdings make up 67% of its $21.3M portfolio in Q1 2022.
  • Empery Asset Management opened 24 new positions and closed 17 in Q1 2022.
  • Empery Asset Management's portfolio value fell 56% quarter-over-quarter to $21.3M.

Based on Empery Asset Management's 13F filing for Q1 2022, filed 16 May 2022.